
The promise of a botanical approach to autism
DDW Editor Reece Armstrong speaks to Joel Stanley, CEO of Ajna BioSciences, about the challenges of developing therapies for autism and why a multi-compound approach may be key to treating symptoms. RA: What are the challenges of discovering and developing effective therapies for autism? JS: Autism is an incredibly broad spectrum, which makes it fundamentally different from… Read More

